Signal Genetics (SGNL) Reports Q1 Loss of Per Share $0.26

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. SPY
7. CVS
8. UNH
9. DAL
10. TMUS

Go back to Signal Genetics (SGNL) Reports Q1 Loss of Per Share $0.26

Signal Genetics Highlights Recent Achievements and Reports First Quarter 2016 Financial Results

May 16, 2016 8:31 AM EDT

CARLSBAD, Calif., May 16, 2016 (GLOBE NEWSWIRE) -- Signal Genetics, Inc. (NASDAQ: SGNL) (Signal or the Company), a commercial stage, molecular genetics diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer, today reported recent achievements and financial results for the first quarter ended March 31, 2016.

Recent Highlights

Record net revenue from clinical customers increased 244% in the first quarter of 2016 over first quarter of 2015Record number of tests billed for clinical customers was 93%... More